s6y

MOLECULAR PARTNERS AG

Ticker
MOLN
CIK
1745114
Industry
Biological Products, (No Diagnostic Substances)

Ownership 7

  1. SC 13D/A Major Shareholders
  2. SC 13D Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G Major Shareholders

Prospectus 8

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  7. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  8. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Other 106

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 106 other filings